List of Tables
Table 1 Europe: Some of the Countries Requiring Medical Supervision for Genetic Testing
Table 2 Price Comparison: DTC Laboratory Tests Vs. Conventional Laboratory Tests (USD)
Table 3 DTC Genetic Testing: Pricing Analysis
Table 4 Global Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 5 Difference Between Conventional Genetic Testing and DTC Genetic Testing
Table 6 Global Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 7 Global Direct-to-consumer Genetic Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 8 Global DTC Genetic Testing Market for Ancestry/Genealogy, by Country/Region, 2021-2030 (USD Million)
Table 9 Global DTC Genetic Testing Market for Diseases Risk Assessment, by Type, 2021-2030 (USD Million)
Table 10 Global DTC Genetic Testing Market for Diseases Risk Assessment, by Country/Region, 2021-2030 (USD Million)
Table 11 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
Table 12 Global Disease Risk Assessment Testing Market for Cancer, by Country/Region, 2021-2030 (USD Million)
Table 13 Global Disease Risk Assessment Testing Market for Cardiovascular Diseases, by Country/Region, 2021-2030 (USD Million)
Table 14 Burden of Neurological Conditions (DALYs Per 100,000 Population)
Table 15 Global Disease Risk Assessment Testing Market for Neurological Diseases, by Country/Region, 2021-2030 (USD Million)
Table 16 Incidence of Common Genetic Disorders
Table 17 Global Disease Risk Assessment Testing Market for Other Diseases, by Country/Region, 2021-2030 (USD Million)
Table 18 Global DTC Genetic Testing Market for Carrier Status, by Country/Region, 2021-2030 (USD Million)
Table 19 Global DTC Genetic Testing Market for Other Genetic Tests, by Country/Region, 2021-2030 (USD Million)
Table 20 Number of People with Diabetes, by Region (2021 Vs. 2030) (In Thousands)
Table 21 Global DTC Diabetes Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 22 Commonly Performed Routine Clinical Testing
Table 23 Global DTC Routine Clinical Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 24 Commonly Tests Included in a Thyroid Panel
Table 25 Global DTC Thyroid Function Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 26 COVID-19 Cases & Deaths, by Region (As of 12th March 2023)
Table 27 Global Direct-to-consumer Laboratory Testing Market for COVID-19 Testing, by Country/Region, 2021-2030 (USD Million)
Table 28 HIV Statistics (2021)
Table 29 Global Direct-to-consumer Laboratory Testing Market for Sexually Transmitted Diseases, by Country/Region, 2021-2030 (USD Million)
Table 30 Commonly Performed DTC Tests for Other Applications
Table 31 Global Direct-to-consumer Laboratory Testing Market for Other Applications, by Country/Region, 2021-2030 (USD Million)
Table 32 Global Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 33 Global Direct-to-consumer Laboratory Testing Market for Blood, by Country/Region, 2021-2030 (USD Million)
Table 34 Global Direct-to-consumer Laboratory Testing Market for Saliva, by Country/Region, 2021-2030 (USD Million)
Table 35 Reason for Conducting a Urine Test
Table 36 Global Direct-to-consumer Laboratory Testing Market for Urine, by Country/Region, 2021-2030 (USD Million)
Table 37 Sample Type for Various Test
Table 38 Global Direct-to-consumer Laboratory Testing Market for Other Samples, by Country/Region, 2021-2030 (USD Million)
Table 39 Global Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 40 North America: Direct-to-consumer Laboratory Testing Market, by Country, 2021-2030 (USD Million)
Table 41 North America: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 42 North America: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 43 North America: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 44 North America: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 45 Price Comparison of Traditional Laboratory Testing Vs. DTC Laboratory Testing in the U.S.
Table 46 U.S.: Key Macro & Micro Indicators
Table 47 U.S.: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 48 U.S.: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 49 U.S.: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 50 U.S.: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 51 Canada: Key Macro Indicators
Table 52 Canada: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 53 Canada: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 54 Canada: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 55 Canada: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 56 Europe: Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 57 Europe: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 58 Europe: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 59 Europe: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 60 Europe: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 61 U.K.: Prevalence of Various Chronic Conditions
Table 62 U.K.: Key Macro Indicators
Table 63 U.K.: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 64 U.K.: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 65 U.K.: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 66 U.K.: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 67 Germany: Key Macro Indicators
Table 68 Germany: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 69 Germany: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 70 Germany: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 71 Germany: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 72 Italy: Key Macro Indicators
Table 73 Italy: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 74 Italy: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 75 Italy: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 76 Italy: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 77 France: Key Macro Indicators
Table 78 France: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 79 France: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 80 France: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 81 France: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 82 Spain: Key Macro Indicators
Table 83 Spain: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 84 Spain: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 85 Spain: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 86 Spain: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 87 Rest of Europe: Percent of Elderly Population (2012 Vs. 2021 Vs. 2022)
Table 88 Rest of Europe: Cancer Statistics (2020 Vs. 2030)
Table 89 Rest of Europe: Diabetes Statistics (2021 Vs. 2030) (In Thousands)
Table 90 Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 91 Rest of Europe: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 92 Rest of Europe: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 93 Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 94 Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 95 Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 96 Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 97 Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 98 Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 99 China: Some of the Direct-to-consumer Genetic Testing Products Comparison
Table 100 China: Key Macro Indicators
Table 101 China: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 102 China: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 103 China: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 104 China: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 105 Japan: Key Macro Indicators
Table 106 Japan: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 107 Japan: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 108 Japan: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 109 Japan: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 110 India: Key Trends in the Direct-to-consumer Laboratory Testing Market
Table 111 India: Key Macro Indicators
Table 112 India: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 113 India: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 114 India: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 115 India: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 116 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 117 Rest of Asia-Pacific: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 118 Rest of Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 119 Rest of Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 120 Rest of Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 121 Rest of Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 122 Latin America: Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 123 Latin America: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 124 Latin America: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 125 Latin America: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 126 Latin America: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 127 Latin America: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 128 Middle East & Africa: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 129 Middle East & Africa: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 130 Middle East & Africa: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 131 Middle East & Africa: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 132 Recent Developments, by Company, 2020-2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Direct-to-consumer Laboratory Testing Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 8 Global Direct-to-consumer Laboratory Testing Market Size, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 9 Direct-to-consumer Laboratory Testing Market Size, by Geography
Figure 10 U.S.: Regulations for DTC Laboratory Testing
Figure 11 Types of Direct-to-consumer Tests and Their Regulatory Pathways
Figure 12 Genome Sequencing Costs, 2010-2021 (USD)
Figure 13 Global Direct-to-consumer Laboratory Testing Market, by Application, 2023-2030 (USD Million)
Figure 14 Process of DTC Genetic Testing
Figure 15 Estimated Number of New Cancer Cases (2020-2040)
Figure 16 Global Direct-to-consumer Laboratory Testing Market, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 17 Benefits of Saliva Sampling
Figure 18 Global Direct-to-consumer Laboratory Testing Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 19 North America: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 20 U.S.: Disposable Personal Income (USD Billion)
Figure 21 Europe: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 22 U.K.: Number of New Sexually Transmitted Infections Diagnosed Per 100,000 Population
Figure 23 Italy: Percentage of Population Aged 65 & Above
Figure 24 Spain: Number of People Living with HIV (2010-2021)
Figure 25 Asia-Pacific: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 26 Japan: Percentage of Population Aged 65 and Above (2010-2030)
Figure 27 Brazil: Number of People with Diabetes (In Thousands)
Figure 28 Argentina: HIV Statistics
Figure 29 Key Growth Strategies Adopted by Leading Players, 2020-2023
Figure 30 Competitive Dashboard: Direct-to-consumer Laboratory Testing Market
Figure 31 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Application
Figure 32 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Region
Figure 33 Global Direct-to-consumer Laboratory Testing Market Share Analysis, by Key Players, 2022 (%)
Figure 34 Quest Diagnostics Incorporated.: Financial Overview (2022)
Figure 35 Laboratory Corporation of America Holdings: Financial Overview (2022)
Figure 36 23andMe Holding Co.: Financial Overview (2021)
Figure 37 Myraid Genetics, Inc: Financial Overview (2022)
Figure 38 Thorne Healthtech, Inc.: Financial Overview (2022)